📰 Stuart Rich News
Page 2 - Stuart Rich News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Stuart Rich. Real-time updates on events, politics, business and more.
October 10, 2022
Positive Data Presented at HFSA Annual Meeting Demonstrate Effects of Oral Levosimendan in Patients with Pulmonary Hypertension and Heart Failure with Preserved Ejection Fraction (PH-HFpEF) - read this article along with other careers information, tips and advice on BioSpace
January 4, 2022
Receives a Notice of Allowance of Multiple Patent Claims for TNX-102 (subcutaneous levosimendan) Successfully Completes IV to Oral Transition Substudy for...
April 9, 2021
25 Tenax Therapeutics, Inc. (NASDAQ: TENX)announced positive data from its Phase 2 HELP Study that evaluated levosimendan in patients with pulmonary hypertension and heart failure with preserved ejection fraction. Levosimendan Improves Hemodynamics and Exercise Tolerance in PH-HFpEF: Results of the Placebo-Controlled HELP Trial was published in the Journal of American College of Cardiology: Heart Failure. The publication had a 84% responder rate during the open la...
April 9, 2021
4 Penny Stocks To Buy With Analysts Expecting 80%-180% Upside These Penny Stocks Have Analysts Bullish Right Now 71 views Author Are Analysts Right About These Penny Stocks? Penny stocks are some of the highest-risk stocks in the market. Thanks to a long history of volatility, manipulation, hype, and speculation, traders seek the ultimate alpha in these cheap shares. But it isn’t just for “wild west” gun-slinging traders. Analysts have also grown bullish on many stocks under $5. Small-...
March 2, 2021
Published: Mar 02, 2021 New Board appointments strengthen Tenax with world-class expertise in cardiovascular drug development, commercial strategy, and business development New Directors will provide significant guidance as Tenax is poised to advance its two leading drug candidates into late-stage clinical testing Transformational step as Tenax strengthens its positioning as a leading specialty pharmaceutical company focused on cardio-pulmonary therapeutics a specialty pharmaceutica...
January 19, 2021
MORRISVILLE –Tenax Therameputics is acquiring an Illinois-based biotech firm with a promising hypertension treatment and named that company’s cofounder as its chief medical officer. Tenax (Nasdaq: TENX) shares soared 38% to $2.45 shortly after the announced deal for PH Precision Med (PHPM) and the appointment of Stuart Rich, MD, as its CMO early Tuesday. Tenax is paying some 12 million shares of stock to PHPM shareholders. PHPM is focused on a potential treatment of pulmonary arterial hyp...
December 18, 2020
Alula Unveils New PRO Partner Program Tools to Help Dealers Finance, Scale and Market Their Business Share Article Alula Pros can access a broad range of services to enable rapid, cost-effective growth “Many security professionals today are looking over their shoulder as tech giants like Amazon make inroads into the connected smart-home and security space,” said Warren Hill, Alula’s Director of Partner Development. “We are offering additional tools and services that help level the playi...